Professor | Xiaotao Jiang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Xiaotao Jiang
Contact Information	jxt_go@foxmail.com
Language ability	English, Chinese
Province	Guangdong

Upload Avatar (500 x 500)

Name

Xiaotao Jiang

Contact Information

jxt_go@foxmail.com

Language ability

English, Chinese

Province

Guangdong

University/Lab Affiliation and Title	Southern Medical University
Faculty	Basic Medical Sciences
Academic Background & Achievements	Bachelor's in Clinical Medicine: First Military Medical University Master's in Immunology: Southern Medical University Ph.D. in Hepatology: Southern Medical University Affiliated Nanfang Hospital Postdoctoral Research: Cancer Center, Augusta University (formerly Georgia Medical College)
Awards	2021: Silver Award in Guangdong 'Entrepreneurship and Innovation Cup' Technology Returnee Leadership Competition 2020: Third Prize in Guangdong University Achievement Roadshow Competition, Biomedicine Group 2020: First Prize in the 6th National Undergraduate Basic Medicine Innovation Research and Experimental Design Forum 2019: Second Prize for Teaching Excellence, Southern Medical University

University/Lab Affiliation and Title

Southern Medical University

Faculty

Basic Medical Sciences

Academic Background & Achievements

Bachelor's in Clinical Medicine: First Military Medical University
Master's in Immunology: Southern Medical University
Ph.D. in Hepatology: Southern Medical University Affiliated Nanfang Hospital
Postdoctoral Research: Cancer Center, Augusta University (formerly Georgia Medical College)

Awards

2021: Silver Award in Guangdong 'Entrepreneurship and Innovation Cup' Technology Returnee Leadership Competition
2020: Third Prize in Guangdong University Achievement Roadshow Competition, Biomedicine Group
2020: First Prize in the 6th National Undergraduate Basic Medicine Innovation Research and Experimental Design Forum
2019: Second Prize for Teaching Excellence, Southern Medical University

Areas of Focus	Cancer Immunotherapy
Publications	Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC, Leidy D. Caraballo Galva, Xiaotao Jiang, Mohamed S. Hussein, Huajun Zhang, Rui Mao, Pierce Brody, Yibing Peng, Aiwu Ruth He, Mercy Kehinde-Ige, Ramses Sadek, Xiangguo Qiu, Huidong Shi, Yukai He, 2021 The immunology and immunotherapy for COVID-19, Yixin Liu, Xinsheng Zhou, Xuan Liu, Xiaotao Jiang, 2021 Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects, Zhuoyan Liu, Xuan Liu, Jiaxin Liang, Yixin Liu, Xiaorui Hou, Meichuan Zhang, Yongyin Li, Xiaotao Jiang, 2021 Identification of the association between HBcAg‐specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay, Chengcong Chen, Xiaotao Jiang, Xuan Liu, Ling Guo, Weibin Wang, Shuqin Gu, Chunhua Wen, Xuan Yi, Libo Tang, Yongyin Li, 2020 Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release, Xuan Liu, Jianyun Wen, Honglei Yi, Xiaorui Hou, Yue Yin, Guofu Ye, Xuedong Wu, Xiaotao Jiang, 2020 Adoptive CD8+ T cell therapy against cancer：Challenges and opportunities, Jiang XT, Xu Y, Liu MF, Xin H, Wang ZM, Huang, L A. Mellor, Wang W, Wu S, 2019 Identification of α‐fetoprotein‐specific T‐cell receptors for hepatocellular carcinoma immunotherapy, Wei Zhu, Yibing Peng, Lan Wang, Yuan Hong, Xiaotao Jiang, Qi Li, Heping Liu, Lei Huang, Juan Wu, Esteban Celis, Todd Merchen, Edward Kruse, Yukai He, 2018

Areas of Focus

Cancer Immunotherapy

Publications

Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC, Leidy D. Caraballo Galva, Xiaotao Jiang, Mohamed S. Hussein, Huajun Zhang, Rui Mao, Pierce Brody, Yibing Peng, Aiwu Ruth He, Mercy Kehinde-Ige, Ramses Sadek, Xiangguo Qiu, Huidong Shi, Yukai He, 2021
The immunology and immunotherapy for COVID-19, Yixin Liu, Xinsheng Zhou, Xuan Liu, Xiaotao Jiang, 2021
Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects, Zhuoyan Liu, Xuan Liu, Jiaxin Liang, Yixin Liu, Xiaorui Hou, Meichuan Zhang, Yongyin Li, Xiaotao Jiang, 2021
Identification of the association between HBcAg‐specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay, Chengcong Chen, Xiaotao Jiang, Xuan Liu, Ling Guo, Weibin Wang, Shuqin Gu, Chunhua Wen, Xuan Yi, Libo Tang, Yongyin Li, 2020
Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release, Xuan Liu, Jianyun Wen, Honglei Yi, Xiaorui Hou, Yue Yin, Guofu Ye, Xuedong Wu, Xiaotao Jiang, 2020
Adoptive CD8+ T cell therapy against cancer：Challenges and opportunities, Jiang XT, Xu Y, Liu MF, Xin H, Wang ZM, Huang, L A. Mellor, Wang W, Wu S, 2019
Identification of α‐fetoprotein‐specific T‐cell receptors for hepatocellular carcinoma immunotherapy, Wei Zhu, Yibing Peng, Lan Wang, Yuan Hong, Xiaotao Jiang, Qi Li, Heping Liu, Lei Huang, Juan Wu, Esteban Celis, Todd Merchen, Edward Kruse, Yukai He, 2018

Immunotherapy Car-T Adoptive Cell Therapy Gene Therapy Monoclonal Antibody Cancer Tumor Molecular Biology Synthetic Biology Antibody-Drug Conjugates

Yang Li - Peking University

Xiaowei Zhang - Peking University

Ying Zhao - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us